Search for: "Abbott Laboratories, Inc."
Results 201 - 220
of 451
Sort by Relevance
|
Sort by Date
19 Oct 2011, 11:27 am
Prometheus Laboratories, Inc., the U.S. [read post]
16 Sep 2011, 11:02 am
The state has already settled cases with Astra Zeneca, Abbott Laboratories, GlaxoSmithKline, Amgen Inc., Baxter Healthcare Corp., Boehringer Ingelhelm Roxane, and Dey Pharmaceutical and has prevailed at trial against Johnson & Johnson and Bristol-Meyers Squibb. [read post]
15 Sep 2011, 5:00 am
Abbott Laboratories, 447 F.3d 861, 867 [read post]
1 Sep 2011, 2:39 am
September 22, 2011 - 2 PM: Abbott Laboratories v. [read post]
24 Aug 2011, 12:33 am
Novartis (IPBiz) Simcor (Niacin, Simvastatin) – US: Abbott Laboratories files patent infringement complaint against Teva in response to Para IV challenge (Patent Docs) Vanos (Fluocinonide) – US: Medicis and Nycomed settle Vanos patent dispute (Patent Docs) Viagra (Sildenafil) – US: Pfizer’s patent on Viagra upheld by the EDVA: Pfizer v Teva (Rocket Docket IP Blog) (Patent Docs) (The IP Factor) [read post]
4 Aug 2011, 2:40 pm
-based Abbott Laboratories Inc. announced its plan to purchase Advanced Medical Optics Inc. through a tender offer. [read post]
4 Aug 2011, 1:38 pm
-based Abbott Laboratories Inc. announced its plan to purchase Advanced Medical Optics Inc. through a tender offer. [read post]
4 Aug 2011, 11:34 am
-based Abbott Laboratories Inc. announced its plan to purchase Advanced Medical Optics Inc. through a tender offer. [read post]
3 Aug 2011, 3:31 am
Paddock (Orange Book Blog) (Holman’s Biotech IP Blog) Cetrorelix – UK: Non-payment of Cetrorelix fee on time fatal for SPC: Case BLO/252/11 The Administrators of the Tulane Education Fund (The SPC Blog) Detrol (Tolterodine tartrate) – US: Pfizer files patent infringement complaint against Torrent Pharma in response to Para IV certification filing (Patent Docs) Galantamine – EU: CJEU ruling in Case C-427/09 Generics (UK) Ltd v Synaptech (The SPC Blog) (EPLAW) Memantine –… [read post]
23 Jul 2011, 2:25 pm
This total does not take into account settlements after Sept. 30, 2010, including but not limited to $600 million in civil penalties that were part of a larger $750 settlement with GlaxoSmithKline involving the manufacture and sale of adulterated drug products and three settlements announced in December 2010: 1) $102 million in civil penalties that were part of a $203.5 million global settlement with Elan Corporation resolving off-label marketing allegations, 2) a $421 million settlement stemming… [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole) –… [read post]
17 Jul 2011, 9:17 pm
Watson Pharmaceuticals et al. 1:11-cv-00607; filed July 8, 2011 in the District Court of Delaware • Plaintiffs: Abbott Laboratories; Abbott Respiratory LLC • Defendants: Watson Pharmaceuticals Inc.; Watson Laboratories Inc. [read post]
30 Jun 2011, 5:00 am
Wyeth Laboratories, 510 F. [read post]
15 Jun 2011, 4:56 am
Impax Laboratories Inc. [read post]
6 Jun 2011, 4:58 pm
At the time, Daughter was a corporate associate in the Los Angeles office of a large, international law firm (the “Firm”) who was working on an impending merger and acquisition involving Abbott Laboratories (“Abbott”) and her Firm’s client, Advanced Medical Optics, Inc. [read post]
6 Jun 2011, 2:22 pm
Goetz, a California attorney, with insider trading in the securities of Advanced Medical Optics, Inc. in advance of the January 12, 2009 announcement that Abbott Laboratories, Inc. would acquire Advanced Medical... [read post]
4 Jun 2011, 5:13 pm
Abbott Laboratories, Inc. [read post]
En Banc Federal Circuit Appeals Court Tightens Materiality and Intent Prongs for Inequitable Conduct
2 Jun 2011, 8:19 am
In the instant case, the lower court had found inequitable conduct by Abbott Diabetes Care Inc., the successor to Therasense Inc. and a subsidiary of Abbott Laboratories as to patents (5,628,890; 5,820,551; 6,143,164; and 6,592,745) directed to a glucose home testing kit for diabetics, including disposable blood glucose test strips. [read post]
29 May 2011, 9:01 pm
Abbott Laboratories et al.v. [read post]
26 May 2011, 7:37 am
Background This case arose from a patent suit in which Abbott Laboratories and its subsidiary, Therasense (collectively “Abbott”) alleged that Becton, Dickinson & Co. and other parties (collectively, “BD”) had infringed Abbott’s patents relating to disposable blood glucose test strips. [read post]
